SOURCE: The Institute for the Study of Aging

August 16, 2005 05:00 ET

Institute for the Study of Aging Sponsors Neurogenesis Catalyst Conference

NEW YORK, NY -- (MARKET WIRE) -- August 16, 2005 -- The Institute for the Study of Aging (ISOA), Ltd., a biomedical venture philanthropy founded by the Lauder family, is sponsoring a one-day catalyst conference entitled Neurogenesis as a Therapeutic Strategy for Cognitive Aging and Alzheimer's Disease on Thursday, September 22, 2005, from 7:30 a.m. to 5:00 p.m., at The Rockefeller University in New York City. Academic and biotechnology industry scientists working in the field of neurodegeneration are welcomed to attend.

The conference will feature 12 leading international experts who will address the role of neurogenesis in normal cognitive function, cognitive aging and Alzheimer's disease, and novel therapeutic strategies. Presentations will also incorporate discussions on small molecules and biological therapeutic approaches, stem cells, and lifestyle interventions to promote neurogenesis. A detailed conference agenda and registration forms are available online at www.aging-institute.org. The registration fee is $100/person, which includes breakfast, lunch, and presentation materials. Seating is limited to 100. The registration deadline is September 9.

This conference is being made possible through generous donations from Ortho-McNeil Neurologics, Inc, and Pfizer, Inc. Co-sponsorship opportunities are still available. For more information, contact Monika Halarewicz at 212-901-8009 or mhalarewicz@aging-institute.org.

About the Institute for the Study of Aging (ISOA)

The Institute for the Study of Aging (ISOA) is a biomedical venture philanthropy whose sole mission is to accelerate the discovery and development of new drugs to prevent, treat and cure Alzheimer's disease and related dementias. Since its founding as a private foundation by the Lauder family in 1998, ISOA has awarded $22.7 million for 133 research programs and conferences at leading academic institutions and biotechnology companies worldwide. In 2004, the Lauder family established a public charity, ISOA, Ltd., to enable individuals, foundations and corporations to partner with the Institute in an effort to raise additional funds and award more grants. For more information, visit http://www.aging-institute.org, or call Howard Fillit, MD (Executive Director) or Suzanne Grossberg (Director of Development) at 212 935 2402.

Contact Information